Clinical Trial Update: Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating remimazolam tosilate for sedation in patients undergoing diagnostic upper GI endoscopy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedation-related Procedural Sedation

Drugs mentioned

• Remimazolam Tosilate (remimazolam)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Sedation | Phase 3 | Status: COMPLETED